These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26151174)

  • 21. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort.
    Langsetmo L; Platt RW; Ernst P; Bourbeau J
    Am J Respir Crit Care Med; 2008 Feb; 177(4):396-401. PubMed ID: 18048806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
    Donaldson GC; Seemungal TA; Bhowmik A; Wedzicha JA
    Thorax; 2002 Oct; 57(10):847-52. PubMed ID: 12324669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring peak expiratory flow could predict COPD exacerbations: A prospective observational study.
    Cen J; Ma H; Chen Z; Weng L; Deng Z
    Respir Med; 2019 Mar; 148():43-48. PubMed ID: 30827473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.
    Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA
    Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.
    Llor C; Molina J; Naberan K; Cots JM; Ros F; Miravitlles M;
    Int J Clin Pract; 2008 Apr; 62(4):585-92. PubMed ID: 18266710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
    Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
    Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes in the nature, severity and frequency of COPD exacerbations.
    Donaldson GC; Seemungal TA; Patel IS; Lloyd-Owen SJ; Wilkinson TM; Wedzicha JA
    Eur Respir J; 2003 Dec; 22(6):931-6. PubMed ID: 14680081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colds as predictors of the onset and severity of COPD exacerbations.
    Johnston NW; Olsson M; Edsbäcker S; Gerhardsson de Verdier M; Gustafson P; McCrae C; Coyle PV; McIvor RA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():839-848. PubMed ID: 28331305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
    Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
    Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P; Jenkins M; O'Brien CD; Fahy WA
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
    Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
    Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year.
    Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Wang C; Bourbeau J
    Eur Respir J; 2010 May; 35(5):1022-30. PubMed ID: 19897555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study evaluating the effect of exacerbations on physical activity in patients with chronic obstructive pulmonary disease.
    Ehsan M; Khan R; Wakefield D; Qureshi A; Murray L; Zuwallack R; Leidy NK
    Ann Am Thorac Soc; 2013 Dec; 10(6):559-64. PubMed ID: 24053416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.